News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
22,096 Results
Type
Article (1164)
Company Profile (1)
Press Release (20931)
Section
Business (3848)
Career Advice (97)
Deals (562)
Drug Development (3045)
Employer Resources (4)
FDA (1141)
Job Trends (549)
News (8761)
Policy (750)
Tag
Academia (125)
Alliances (1479)
ALS (1)
Alzheimer's disease (80)
Approvals (1162)
Artificial intelligence (19)
Bankruptcy (6)
Best Places to Work (571)
Biosimilars (7)
Bladder cancer (7)
Breast cancer (8)
Cancer (87)
Cardiovascular disease (4)
Career advice (76)
Career pathing (1)
CAR-T (2)
Cell therapy (5)
Cervical cancer (5)
Clinical research (2680)
Collaboration (32)
Compensation (9)
COVID-19 (30)
CRISPR (1)
C-suite (5)
Cystic fibrosis (2)
Data (120)
Diabetes (17)
Diagnostics (255)
Digital health (1)
Drug discovery (13)
Earnings (1314)
Employer branding (2)
Employer resources (4)
Events (2711)
Executive appointments (19)
FDA (1237)
Featured Employer (1)
Funding (21)
Gene editing (1)
Generative AI (1)
Gene therapy (22)
GLP-1 (8)
Government (86)
Guidances (1)
Healthcare (592)
Huntington's disease (1)
Immunology and inflammation (4)
Indications (2)
Infectious disease (31)
Inflammatory bowel disease (2)
Intellectual property (1)
Interviews (15)
IPO (200)
Job creations (24)
Job search strategy (50)
Kidney cancer (2)
Layoffs (3)
Legal (50)
Liver cancer (5)
Lung cancer (19)
Lymphoma (2)
Machine learning (1)
Management (2)
Manufacturing (4)
Medical device (1060)
Medtech (1060)
Mergers & acquisitions (377)
Metabolic disorders (25)
Multiple sclerosis (2)
Neurodegenerative disease (4)
Neuropsychiatric disorders (2)
Neuroscience (93)
NextGen: Class of 2025 (188)
Non-profit (162)
Northern California (95)
Now hiring (1)
Obesity (6)
Opinion (4)
Ovarian cancer (2)
Pain (4)
Parkinson's disease (5)
Patient recruitment (5)
People (826)
Phase I (603)
Phase II (1186)
Phase III (1086)
Pipeline (44)
Postmarket research (135)
Preclinical (176)
Prostate cancer (3)
Radiopharmaceuticals (20)
Rare diseases (8)
Real estate (90)
Regulatory (698)
Reports (2)
Research institute (78)
Resumes & cover letters (34)
Schizophrenia (1)
Series A (3)
Series B (4)
Southern California (58)
Startups (80)
Supply chain (1)
United States (820)
Vaccines (1)
Venture capitalists (1)
Weight loss (2)
Women's health (1)
Date
Today (11)
Last 7 days (31)
Last 30 days (96)
Last 365 days (1247)
2025 (406)
2024 (1314)
2023 (1547)
2022 (1930)
2021 (1974)
2020 (1744)
2019 (1645)
2018 (1212)
2017 (1301)
2016 (1260)
2015 (1359)
2014 (888)
2013 (701)
2012 (811)
2011 (852)
2010 (639)
Location
Africa (20)
Arizona (4)
Asia (1165)
Australia (214)
California (206)
Canada (44)
China (13)
Colorado (3)
Connecticut (6)
Delaware (7)
Europe (2948)
Florida (19)
Georgia (15)
Illinois (26)
India (2)
Indiana (10)
Iowa (1)
Japan (17)
Kansas (1)
Maine (1)
Maryland (8)
Massachusetts (192)
Michigan (35)
Minnesota (25)
Missouri (2)
Nebraska (1)
New Hampshire (6)
New Jersey (86)
New Mexico (1)
New York (40)
North Carolina (40)
Northern California (95)
Ohio (8)
Oregon (1)
Pennsylvania (24)
Rhode Island (3)
South America (31)
South Carolina (1)
Southern California (58)
Tennessee (9)
Texas (27)
Utah (6)
Virginia (5)
Washington D.C. (1)
Washington State (12)
Wisconsin (1)
22,096 Results for "visualant".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
LUMA Vision Receives FDA Clearance for VERAFEYE 2D/4D Cardiac Visualization Platform
April 16, 2025
·
3 min read
Press Releases
RadiusXR and Glaukos Corporation Announce a New Collaboration With Topcon Healthcare, Inc. and the Launch of Inspire®: A Next-Generation Visual Field Solution
March 11, 2025
·
7 min read
Press Releases
Vergent Bioscience Completes Enrollment in Phase 2 VISUALIZE Trial Evaluating Potential of Abenacianine for Injection (VGT-309) to Improve Tumor Visualization During Cancer Surgery
November 13, 2024
·
4 min read
Genetown
SYFOVRE® (pegcetacoplan injection) Preserved Visual Function at 36 Months in GALE Extension Study in Geographic Atrophy (GA)
Apellis Pharmaceuticals, Inc. announced that SYFOVRE® preserved visual function at 36 months in patients with geographic atrophy secondary to age-related macular degeneration.
June 10, 2024
·
8 min read
Press Releases
LUMA Vision Successfully Completes First-in-Human Procedures with its Novel VERAFEYE™ Navigation and Visualization Platform
January 14, 2025
·
3 min read
Press Releases
Visual Arts Therapy Market Size to Reach USD 3.67 billion by 2030, Says Coherent Market Insights
January 16, 2025
·
1 min read
Pharm Country
Ansys Enables 3D Multiphysics Visualization of Next-Generation 3D-IC Designs with NVIDIA Omniverse
Ansys (NASDAQ: ANSS) today announced that it is adopting NVIDIA Omniverse application programming interfaces (APIs) to offer 3D-IC designers valuable insights from Ansys’ physics solver results through real-time visualization.
June 19, 2024
·
3 min read
Biotech Bay
Anatomage Empowers Institutions to Flip Classrooms with Interactive Digital Anatomy & Physiology Curriculum Featuring Real Anatomy Visuals
Anatomage Inc., a leader in medical visualization technology, announced technological enhancements to Anatomage Lessons.
April 10, 2024
·
4 min read
Policy
Bausch + Lomb Receives Health Canada Approval for enVista® Envy™* Full Visual Range Intraocular Lens
Bausch + Lomb Corporation, a leading global eye health company dedicated to helping people see better to live better, announced that Health Canada has approved the enVista® Envy™* full visual range intraocular lens.
May 28, 2024
·
4 min read
Press Releases
Perfuse Therapeutics Announces Positive Visual, Structural and Safety Data from a Ph1/2a Trial of PER-001 in Glaucoma Patients at the American Glaucoma Society Meeting
March 3, 2025
·
5 min read
1 of 2,210
Next
